Pathogenic Species and Genotypes of Bacterial Diversity in Relation to the Severity of Dental Caries
NCT ID: NCT02056262
Last Updated: 2020-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
56 participants
OBSERVATIONAL
2016-03-15
2017-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caries Risk Assessment in Children and Adolescents in the Alpes Maritimes (France)
NCT01372436
Validity of ICDAS Versus ICCMS
NCT03188952
Assessment of Salivary Bacterial Level and Dental Caries Experience in a Group of Egyptian Children With Black Stained Teeth
NCT03563469
Prevention of Dental Caries Lesions With Fluoride Varnish in Erupting First Permanent Molars
NCT02592278
Prevalence of Teeth Discoloration , Associated Risk Factors and the Most Common Shade Among Group of Egyptian Population
NCT06515561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Compare the distribution of bacterial species in relation to stages of severity of caries
* Compare the results from plaque with those of saliva samples.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3 to 16 years of age
Volunteers of 3 to 16 years of age, coming in to the hospital for a dental consultation. See inclusion/exclusion criteria.
Intervention: Dental cavity evaluation Intervention: Saliva sampling Intervention: Plaque sampling
Dental cavity evaluation
The dental cavities present will be evaluated using the ICDAS (International Caries Detection and Assessment System).
Saliva sampling
A saliva sample will be harvested.
Plaque sampling
Plaque samples from a healthy tooth and a tooth with a cavity will be harvested.
17 - 45 years of age
Volunteers of 17 to 45 years of age, coming in to the hospital for a dental consultation. See inclusion/exclusion criteria.
Intervention: Dental cavity evaluation Intervention: Saliva sampling Intervention: Plaque sampling
Dental cavity evaluation
The dental cavities present will be evaluated using the ICDAS (International Caries Detection and Assessment System).
Saliva sampling
A saliva sample will be harvested.
Plaque sampling
Plaque samples from a healthy tooth and a tooth with a cavity will be harvested.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dental cavity evaluation
The dental cavities present will be evaluated using the ICDAS (International Caries Detection and Assessment System).
Saliva sampling
A saliva sample will be harvested.
Plaque sampling
Plaque samples from a healthy tooth and a tooth with a cavity will be harvested.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minors must have parental permission
* The patient must have given his/her informed and signed consent
Exclusion Criteria
* The patient is in an exclusion period determined by a previous study
* The patient is pregnant, or breastfeeding
* The patient has been on antibiotics within the past two months
* Smokers
* Teeth under current care
* Parodontopathy
* Use of a mouthwash within the last week
* Insufficient numbers of healthy and/or teeth with carious lesions for carrying out the study
3 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hervé Léon, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Montpellier - Centre de Soins, d'Enseignement et de Recherche Dentaires
Montpellier, , France
CHRU de Montpellier - Hôpital La Colombière
Montpellier, , France
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01213-42
Identifier Type: OTHER
Identifier Source: secondary_id
AOI/2012/LH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.